Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Hepatology (Baltimore, Md.)
|
May 29, 2019
Is Trimming the Fat Enough? Fibroblast Growth Factor 21 as An Emerging Treatment for Nonalcoholic Fatty Liver Disease
Jody Dushay, Michelle Lai
The Journal of Family Practice
|
April 20, 2010
Insulin therapy for type 2 diabetes: making it work
Jody Dushay, Martin J Abrahamson
JAMA Internal Medicine
|
December 1, 2025
Coprescribing GLP-1 Receptor Agonists and Lifestyle-Reply
Farhad Mehrtash, Jody Dushay, JoAnn E Manson
JAMA Internal Medicine
|
July 14, 2025
I Am Taking a GLP-1 Weight-Loss Medication-What Should I Know?
Farhad Mehrtash, Jody Dushay, JoAnn E Manson
JAMA Internal Medicine
|
July 14, 2025
Integrating Diet and Physical Activity When Prescribing GLP-1s-Lifestyle Factors Remain Crucial
Farhad Mehrtash, Jody Dushay, JoAnn E Manson
Diabetes Care
|
November 2, 2011
Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes
Jody Dushay, Chuanyun Gao, Gosala S Gopalakrishnan, et al.
Journal of the American Heart Association
|
January 23, 2025
Effects of Age and Sex on Systemic Inflammation and Cardiometabolic Function in Individuals With Type 2 Diabetes
Jody Dushay, Eva S Rickers, Enya Wang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 20, 2024
Effects of Age and Sex on Systemic Inflammation and Cardiometabolic Function in Individuals with Type 2 Diabetes
Jody Dushay, Eva S Rickers, Enya Wang, et al.
Gastroenterology
|
May 11, 2010
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease
Jody Dushay, Patricia C Chui, Gosala S Gopalakrishnan, et al.
BMC Obesity
|
November 10, 2018
Multi-sensor ecological momentary assessment of behavioral and psychosocial predictors of weight loss following bariatric surgery: study protocol for a multicenter prospective longitudinal evaluation
Stephanie P Goldstein, J Graham Thomas, Sivamainthan Vithiananthan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Hepatology (Baltimore, Md.)
|
May 29, 2019
Is Trimming the Fat Enough? Fibroblast Growth Factor 21 as An Emerging Treatment for Nonalcoholic Fatty Liver Disease
Jody Dushay, Michelle Lai
The Journal of Family Practice
|
April 20, 2010
Insulin therapy for type 2 diabetes: making it work
Jody Dushay, Martin J Abrahamson
JAMA Internal Medicine
|
December 1, 2025
Coprescribing GLP-1 Receptor Agonists and Lifestyle-Reply
Farhad Mehrtash, Jody Dushay, JoAnn E Manson
JAMA Internal Medicine
|
July 14, 2025
I Am Taking a GLP-1 Weight-Loss Medication-What Should I Know?
Farhad Mehrtash, Jody Dushay, JoAnn E Manson
JAMA Internal Medicine
|
July 14, 2025
Integrating Diet and Physical Activity When Prescribing GLP-1s-Lifestyle Factors Remain Crucial
Farhad Mehrtash, Jody Dushay, JoAnn E Manson
Diabetes Care
|
November 2, 2011
Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes
Jody Dushay, Chuanyun Gao, Gosala S Gopalakrishnan, et al.
Journal of the American Heart Association
|
January 23, 2025
Effects of Age and Sex on Systemic Inflammation and Cardiometabolic Function in Individuals With Type 2 Diabetes
Jody Dushay, Eva S Rickers, Enya Wang, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 20, 2024
Effects of Age and Sex on Systemic Inflammation and Cardiometabolic Function in Individuals with Type 2 Diabetes
Jody Dushay, Eva S Rickers, Enya Wang, et al.
Gastroenterology
|
May 11, 2010
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease
Jody Dushay, Patricia C Chui, Gosala S Gopalakrishnan, et al.
BMC Obesity
|
November 10, 2018
Multi-sensor ecological momentary assessment of behavioral and psychosocial predictors of weight loss following bariatric surgery: study protocol for a multicenter prospective longitudinal evaluation
Stephanie P Goldstein, J Graham Thomas, Sivamainthan Vithiananthan, et al.
Page
of 2